Company intelligence / Profile preview
AskGene Pharma
Camarillo, California, United Statesask-gene.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
AskGene’s lead asset ASKB589, a second-generation anti-Claudin18.2 monoclonal antibody with ADCC enhancement, has entered pivotal Phase III trials in China for first-line treatment of advanced gastric and gastroesophageal junction cancers in combination with chemotherapy and a PD‑1 inhibitor. Over two hundred patients have been enrolled across earlier studies with no dose-limiting toxicities observed to date; maximum tolerated dose not yet reached as of early clinical data reporting. The company also has multiple cytokine prodrug programs leveraging its proprietary SmartKine® platform at various stages from preclinical to clinical development.[6][8][9]
- Therapeutic areas
- OphthalmologyOncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Fusion proteinsAntibody fusion proteinsBispecific antibodiesRecombinant polypeptides[5][8]
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on AskGene Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AskGene Pharma.